Thromboxane antagonism and cough induced by angiotensin-converting-enzyme inhibitor

Lancet

Volumn 349, Issue 9070, 1997, Pages 15-18

  Malini, Pier Luigi ^a   Strocchi, Enrico ^a   Zanardi, Melissa ^a   Milani, Massimo ^a   Ambrosioni, Ettore ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

11 OXOTHROMBOXANE B2; 6 OXOPROSTAGLANDIN F1 ALPHA; ARACHIDONIC ACID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ENDOPEROXIDE; PICOTAMIDE; PROSTACYCLIN; PROSTAGLANDIN; THROMBOXANE; THROMBOXANE RECEPTOR BLOCKING AGENT; THROMBOXANE SYNTHASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG ABSORPTION; DRUG EFFICACY; DRUG URINE LEVEL; ENZYME INHIBITION; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; MALE; METABOLISM; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RANDOMIZED CONTROLLED TRIAL; URINE LEVEL;

EID: 0030925888     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0140-6736(96)12045-6     Document Type: Article

References (23)

1. Israili ZH, Dallas Hall W. Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy: a review of the literature and pathophysiology. Ann Intern Med 1992; 117: 234-42.
2. Igic R. Angiotensin I converting enzyme of the lung. Circ Res 1972: 30 (suppl 2): 51-61.
3. Fuller RW, Dixon CMS, Cuss FMC, Barnes PJ. Bradykinin-induced bronchoconstriction in humans. Am Rev Respir Dis 1987; 135: 176-80.
4. Swartz SL, Williams GH. Angiotensin-converting enzyme inhibition and prostaglandins. Am J Cardiol 1982; 49: 1405-09.
5. Coleridge HM, Coleridge JC, Ginzel KH, Baker GD, Banzett RB, Morrison MA. Stimulation of irritant receptors and afferent C-fibres in the lungs by prostaglandins. Nature 1976; 264: 451-53.
6. Kim RB, Wilson TW Effects of indomethacin on furosemide induced renal prostaglandin synthesis and action in man. Invest Med 1986; 9: 192-97.
7. Waslen TA, McCauley FA, Wilson TW. Sulindac does not spare renal prostaglandins. Clin Invest Med 1989; 12: 77-81.
8. Gilchrist NL, Richards AM, March M, Nicholls MG. Effects of sulindac on angiotensin converting enzyme inhibitor-induced cough: randomised placebo-controlled double-blind cross-over study. J Hum Hypertens 1989; 3: 451-55.
9. Fogari R, Zoppi A, Tettamanti F, Malamani GD, Tinelli C, Salvetti A. Effects of nifedipine and indomethacin on cough induced by angiotensin-converting enzyme inhibitors: a double-blind, randomized, cross-over study. J Cardiovasc Pharmacol 1992; 19: 670-73.
10. 2 and the effect of aspirin. Prostaglandins 1980; 20: 547-57.
11. Minuz P, Barrow SE, Cockcroft JR, Ritter JM. Effects of non-steroidal anti-inflammatory drugs on prostacyclin and thromboxane biosynthesis in patients with mild essential hypertension. Br J Clin Pharmacol 1990; 30: 519-26.
12. Gresele P, Deckmyn H, Arnout J, Nenci GG, Vermylen J. Characterization of N,N-bis(3picolyl)-4-methoxy-isophtalamide (Picotamide) as a dual thromboxane synthase inhibitor/thromboxane A2 receptor antagonist in human platelets. Thromb Haemost 1989; 61: 479-84.
13. 2 recpetor antagonist. Br J Pharmacol 1994; 112: 81-85.
14. Balsano F, Violi F, and the ADEP Group. Effect of picotamide on the clinical progression of peripheral vascular disease. Circulation 1993; 87: 1563-69.
15. Fossati T, Parisi S, Abbiati G, Castiglioni C. Determination of picotamide in human plasma and urine by high-performance liquid chromatography. J Chromatography 1992; 577: 382-86.
16. Hills M, Armitage P. The two-period cross-over clinical trial. Br J Clin Pharmacol 1979; 8: 7-20.
17. 2-synthase inhibitor and receptor antagonist, on human platelets. Eur J Clin Pharmacol 1990; 39: 495-500.
18. Patrono C. Biosynthesis and pharmacologic modulation of thromboxane in humans. Circulation 1990; 81 (suppl I): I-12-I-15.
19. 2 in bradykinin-induced human isolated small bronchi contraction. Eur J Pharmacol 1995; 278: 49-54.
20. Kohrogi H, Graf PD, Sekizawa K, Borson DB, Nadel JA. Neutral endopeptidase inhibitors potentiate substance P - and capsaicininduced cough in awake guinea pigs. J Clin Invest 1988; 82: 2063-68.
21. Strocchi E, Malini PL, Valtancoli G, Ricci C, Bassein L, Ambrosioni E. Cough during treatment with angiotensin-converting enzyme inhibition: analysis of predisposing factors. Drug Invest 1992; 4: 69-72.
22. Tomaki M, Ichinose M, Miura M, et al. Angiotensin converting enzyme inhibitor-induced cough and substance P. Thorax 1995; 51: 199-201.
23. Lacourciere Y, Brunner H, Irwin R, et al. Effects of modulators of the renin-angiotensin-aldosterone system on cough. J Hypertens 1994; 12: 1387-93.